Macular Hole
Presenter: Dr Nusrat Jahan Bukhari
Moderator: Dr Archis Shedbale
 Case Presentation
 Introduction
 Classification
 History
 Pathogenesis
 OCT classification
 Clinical Features
 Investigation
 Treatment
 Recent Advances
Case Presentation
 45 yr old male pt Mr ABC came in April 2012 with c/o
sudden DOV since few days, gave a h/o RE injury
(Blunt Trauma) with a Vn of 6/18, N12, diagnosed
Traumatic Maculopathy
 August 2014 Vn in RE dropped to FC 11/2metre, on
retinal examination diagnosed Traumatic Macular
Hole
 In Jan 2015 Patient underwent RE Vit+ ILM Peeling+
FAE+ C3F8 , Day 1 post op Vn improved to FC 2metre
Case Presentation:
 c/o DOV in RE since April 2012
 O/E RE LE
 Ant Seg: WNL WNL
 IOP: 20 mmHg 17 mm Hg
 Fundi: Traumatic 0.4:1
Macular Hole
Introduction
 A full-thickness depletion of the neural retinal tissue
in the center of the macula#
 Most commonly unilateral**
 Atraumatic “idiopathic” macular holes of the elderly
comprise the vast majority of these lesions*
* Colin A. McCannel et al. Population Based Incidence of Macular Holes.
Ophthalmology. 2009 Jul; 116(7): 1366–1369
** Chew E, Sperduto R, Hiller R, et al: Clinical course of macular holes. Arch Ophthalmol
117:242, 1999
# Chapter: Macular Hole, Yanoff & Duker Ophthalmology
 Sen P et al evaluated the prevalence of Macular Hole
in a study conducted in south India
 1.7 / thousand population
Sen P et al, Prevalence of idiopathic macular hole in adult rural and urban south
Indian population.Clin Experiment Ophthalmol 2008 Apr;36(3):257-60
Colin A. McCannel et al. Population Based Incidence of Macular Holes. Ophthalmology.
2009 Jul; 116(7): 1366–1369
Etiology
 Common causes:
 Idiopathic
 Trauma
 high myopia
 Other causes:
 cystoid macular edema
 proliferative diabetic retinopathy
 severe hypertensive retinopathy
 Choroidal neovasculatrisation
 Solar retinopathy
Classification
 Primary macular hole: is commonly an idiopathic
macular hole
 Caused by vitreous traction on the foveal from an
abnormal vitreous seperation
 Secondary Macular hole: caused by other pathologies
not associated with vitereomacular traction
 blunt trauma, high myopia, macular telangiectasia type2,
diff causes of macular oedema
History
 Macular hole first recognized approximately 100 years
ago
 First described by Knapp in late 1800s
 Later described by Noyes
 First histopathologic descriptions of full-thickness
macular holes were provided by Fuchs (1901)* and
Coats (1907)**
 Gass first described a series of stages of formation of
idiopathic macular hole in 1988
*Fuchs E. Zur Veranderung der Macula Lutea Nach Contusion. Ztschr Augenheilk 1901;6:181
**Coats G. The pathology of macular holes. Roy Lond Hosp Rep 1907; 17-69
Pathogenesis
 Traumatic Theory*
 associated with direct or indirect ocular trauma
 Trauma causes immediate macular hole formation from
mechanical energy created by vitreous fluid waves and
contrecoup macular necrosis or laceration
 More common in young boys
*Kopp CJ.Macular holes:a clinical contribution.Am ophthalmology 1908; 11:518-528
 Cystoid degeneration theory*:
 cystic degeneration of the central macula
 due to :hypertension, retinal vessel occlusion, trauma
 Cyst coalescence FTMH
*Coats G. The pathology of macular holes. Roy London Hospital Report 1907; 17:69-96
 Vascular theory:
 Age related changes of retinal vasculature
cystoid degeneration
macular hole formation
 Vitreous Theory:
 Antero posterior fibrous traction band
Macular traction
Macular cystoid degeneration
Macular hole
Current theory Posterior hyaloid applies
traction to the
foveola/umbo and
causes it to stretch
umbo dehisces because
it is the thinnest point in
the fovea
middle and inner retina
absorbs vitreous fluid at
the exposed edges of the
hole and begins to swell
hole enlarges because of
a lateral extension of
fluid into the outer
plexiform layer
inner retina is breached
due to the hydration of
the fovea and perifoveal
macula, the macular
hole progresses
 Concept of tangential traction*
 Spontaneous tangential traction of external part of the
perifoveolar cortical vitreous detaches foveolar retina
 Creates an intraretinal yellow spot approximately 100-
200μm in diameter
 Yellow color may result from intraretinal xanthophyll
pigment
* Avila MP, Jalkh AE, Murakami K, et al. Biomicroscopic study of the vitreous in macular
breaks. Ophthalmol 1983; 90:1277-83
Role of ILM in pathogenesis of
Macular Hole
scaffold for proliferation
of cellular components
Like myofibroblasts,
fibrocytes,RPE cells,
fibrous astrocyts
Causing tangential
traction around fovea
FTMH formation
May also contribute to
enlargement of MH
Revised Gass classification:
 Gass first described a series of stages of formation of
idiopathic macular hole *
*GASS JIM. Reappraisal of biomicroscopically 0f stages of Development of a macular Hole. Am
J Ophthalmolgy.1995; 119 :752-59
Stage 1 a
 Spontaneous tangential
traction of prefoveolar
cortical vitreous detaches
foveolar retina
creating an intraretinal
enhanced lipofuscin-
colored yellow spot 100-
200μm in diameter
Decreased/ absent foveal
depression
Foveolar detachment
Retinal Pigment
Epithelium
Neurosensory RetinaPosterior Hyaloid
Normal Fovea
Stage 1 b
 Further traction causes
foveal detachment
 yellow spot ˆ200-300μm in
diameter
Foveal detachment
Stage 2
 First biomicroscopically identifiable full thickness
retinal defect
 Less than 400μ
Early hole, central
Early hole, eccentric
Stage 3
 Vitreofoveal seperation
 Enlarges to greater
than 400μ
 Complete PVD is
absent
Stage 3 Hole
Stage 4
 Complete posterior vitreous detachment
(Weiss’ ring) occurs in 20% - 40% of eyes
Stage 4 Hole
vitreous adhesion to
central macula with no
demonstrable retinal
morphology changes
vitreous adhesion to
central macula , demonstrable
changes like tissue cavitation,
cystoid changes, loss of foveal
contour, elevation of fovea
Jay S et al. The International Vitreomacular Traction Study Group. Classification of vitreomacular
adhesion, traction & macular hole. The American Academy of Ophthalmolgy. 2013.2611-19.
OCT based anatomic classification of
FTMH
Small Hole ≥250μ, round or have a
f flap adherent to vitreous,
operculum ₊/-
Medium FTMH hole 250 - 400μ,
• round/ flap adherent to vitreous
Large FTMH hole >400μ,
• vitreous more likely to be fully seperated
• from macula
Jay S et al. The International Vitreomacular Traction Study Group. Classification of vitreomacular
adhesion, traction & macular hole. The American Academy of Ophthalmolgy. 2013.2611-19.
OCT based anatomic classification of
FTMH
Clinical features
 Visual acuity the first indicator but sometimes
misleading
 Mild loss of central vision (Stage 1a & 1b)
 Metamorphopsia
 FTMH is diagnosed on slitlamp biomicroscopy
 By off centering the beam we can study the contour
of hole and vitreous interface
differentiates FTMH from other lesions
Positive & Negative Watzke - Allen Sign
Watzke RC, Allen L. Subjective slit- beam sign for macular disease. Am J Ophthalmol
1969; 449 - 453
 In eyes with ERM a fibrotic appearance with
distortion of perifoveal vessels seen
 Amsler Grid:
 Small absolute scotomas can be detected in 30 -40 %
of patients*
 Charting used but not specific for macular hole
 Can be used in post operative period to evaluate
scotoma and metamorphopsia
*Smith RG et al. Visual Performance in idiopathic macular holes. Eye 1990; 4: 190 -
194
Investigations
 OCT
 FFA
 Optical coherence tomography (OCT):
 diagnosis of macular hole but also in staging
 helpful in prognosticating depending upon size of the
macular hole
 Flourescein Angiography:
 Usually not indicated in diagnosis of macular hole
 But generally demonstrates early hyperfluoresence
(window defect)
 Laser Aiming Beam Test:
 Place a 50μm laser photocoagulator aiming beam
within a lesion
 Patient with FTMH cannot detect the aiming beam
within lesion but is able to detect it in its surrounding
 Patients with ERM or Pseudomacular hole shall be
able to detect
 B- Scan Ultrasonography:
 Predictive of vitreomacular relationship and therefore
may be helpful in staging
Differential Diagnosis
 Epiretinal membrane with pseudomacular hole
 Lamellar macular hole
 Chronic cystoid macular edema
ERM with Pseudomacular hole
 have a median visual acuity of 20/30
 retinal vascular tortuosity
 not associated with a rim of subretinal fluid
Lamellar macular hole
 Sharply circumscribed
 Partial-thickness defects of the macula
 Represents either as an aborted full-thickness lesions
or a complication of chronic cystoid macular edema*
 Characterized by a flat, reddish hue-type lesion with
intact outer retinal tissue
 Careful evaluation will reveal retinal tissue in the base
of the lesion
 No evidence of subretinal fluid
 Do not progress to full-thickness lesions
* Patel B, Duvall J, Tullo AB. Lamellar macular hole associated with idiopathic
juxtafoveolar telangiectasia. Br J Ophthalmol 1988;72:550
Lamellar Macular Hole
Chronic cystoid macular edema
 Seen sometimes post cataract surgery
 In diabetic macular edema
Pre operative parameters
Hole form factor > 0.9 and Macular Hole
index > 0.5 also have a better prognosis
a = base diameter, b = minimum diameter
c = left arm length, d = right arm length
Correlation of hole form factor and best
corrected postoperative visual acuity
S. Ullrich et al. Macular hole size as a prognostic factor in macular hole surgery.
Br J Ophthalmol. 2002 Apr; 86(4): 390–393
Management
 Symptoms of impending holes : visual distortion,
decreased visual acuity, and changes observed with
home Amsler grid testing
 Macular holes can resolve spontaneously
 This most commonly occurs in stage 1 but has been
reported for stage 2 holes as well
 The resolution occurs when the posterior hyaloid
separates
 Hence, it is better to observe them for a few months
 If vision deteriorates or the hole progresses, vitreous
surgery is indicated
Management
Surgery
 Pars Plana Vitrectomy with internal limiting
membrane peeling with gas tamponade is performed
for stage 2-4 FTMH
Pars Plana surgical procedures
 Using three- port system
 After removing central vitreous the posterior cortical
vitreous is identified and seperated from retinal
surface
Chromovitrectomy
 Use of vital dyes to stain pre retinal tissues during
vitreoretinal surgery
 Allows visualization of the thin, transparent tissues in
vitreoretinal interface : ILM, epiretinal ERM, or the
vitreous posterior surface
 Indocyanine Green Dye(ICG): 0.25mg/ml
 Trypan Blue(0.15%): stains ERM, but not ILM
 Triamcinalone Acetonide(40mg/ml): stains residual
vitreous
 Brilliant Blue(0.025% & 0.05%): excellent stain for ilm,
relatively non toxic
 In idiopathic FTMH the rationale would be to remove
or relieve foveal traction from within the retinal
surface1
 Helps by ensuring complete removal of any epiretinal
tissue above the ILM that could cause foveal traction2
as well as by increased cytokine release
 enhancing glial proliferation
ILM Peeling
1- Fekrat S, Wendel RE, de la Cruz Z, Green WR: clinicopathologic correlation of an epiretinal
membrane associated with a recurrent macular hole. Retina 1995; 1:53-57
2- Yooh HS, Brooks HL Jr, Capone A Jr, et al. Ultra structural features of tissue removed during
idiopathic macular hole surgery. Am J Ophthalmol 1996;1:67-75
Types of closure
 On the basis of post operative OCT findings closed
macular holes are:
 Type 1 & type 2 closure
S W Kang et al. Types of macular hole closure and their clinical implications.
Br J Ophthalmol 2003; 87: 1015 - 1019
Type 1 Closure
 Indicates that macular hole is closed without foveal
defect of the neurosensory retina
V/A: 6/36, N 10
Type 2 closure
 Indicates a foveal defect of neurosensory retina
persists postoperatively
 Although thewhole rim of macular hole is attached to
the underlying RPE with flattening of the cuff
Post operative parameters
 OCT parameters: Type 1 closure of MH without
neurosensory defect) has a better visual outcome
compared to Type 2 closure (with neurosensory
defect)
 Continuous IS/OS junction and external limiting membrane as well as
increased photoreceptor outer segment thickness predicts a better
functional outcome
1Kang ST, Ahn K, Ham DI. Types of macular hole closure and their clinical
implications. Br J Ophthalmol. 2003; 87:1015-19
2San M, Shimoda Y, Hashimoto H.Restored photoreceptor outer segment and visual
recovery after macular hole closure . Am J Ophthalmol 2009; 147:313-18
Recent Advances
Pharmacologic vitreolysis
 new nonsurgical option that can aid closure of
macular holes associated with VMT
 degrades the macromolecular vitreous attachment
complex
 relieves the tractional forces that cause the foveal
lesion
 In MIVI TRUST study patients with FTMHs less than
400 microns in width, the closure of holes occurred in
40.6% of ocriplasmin treated eyes and 10.6% of
placebo treated eyes*
 In patients with small hole the success rate was even
higher
 This occurred without face down position, surgery or
gas bubble
 Makes it an appealing option for appropriate patients
* Stalmans P, Benz MS, Gandorfer A, Kampik A.et al. MIVITRUSTal study group.
Enzymatic vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular
holes.N Engl J Med 2012; 367: 606-15
Pharmacologic vitreolysis
Macular hole
Macular hole

Macular hole

  • 1.
    Macular Hole Presenter: DrNusrat Jahan Bukhari Moderator: Dr Archis Shedbale
  • 2.
     Case Presentation Introduction  Classification  History  Pathogenesis  OCT classification  Clinical Features  Investigation  Treatment  Recent Advances
  • 3.
    Case Presentation  45yr old male pt Mr ABC came in April 2012 with c/o sudden DOV since few days, gave a h/o RE injury (Blunt Trauma) with a Vn of 6/18, N12, diagnosed Traumatic Maculopathy  August 2014 Vn in RE dropped to FC 11/2metre, on retinal examination diagnosed Traumatic Macular Hole  In Jan 2015 Patient underwent RE Vit+ ILM Peeling+ FAE+ C3F8 , Day 1 post op Vn improved to FC 2metre
  • 4.
    Case Presentation:  c/oDOV in RE since April 2012  O/E RE LE  Ant Seg: WNL WNL  IOP: 20 mmHg 17 mm Hg  Fundi: Traumatic 0.4:1 Macular Hole
  • 6.
    Introduction  A full-thicknessdepletion of the neural retinal tissue in the center of the macula#  Most commonly unilateral**  Atraumatic “idiopathic” macular holes of the elderly comprise the vast majority of these lesions* * Colin A. McCannel et al. Population Based Incidence of Macular Holes. Ophthalmology. 2009 Jul; 116(7): 1366–1369 ** Chew E, Sperduto R, Hiller R, et al: Clinical course of macular holes. Arch Ophthalmol 117:242, 1999 # Chapter: Macular Hole, Yanoff & Duker Ophthalmology
  • 7.
     Sen Pet al evaluated the prevalence of Macular Hole in a study conducted in south India  1.7 / thousand population Sen P et al, Prevalence of idiopathic macular hole in adult rural and urban south Indian population.Clin Experiment Ophthalmol 2008 Apr;36(3):257-60
  • 8.
    Colin A. McCannelet al. Population Based Incidence of Macular Holes. Ophthalmology. 2009 Jul; 116(7): 1366–1369
  • 9.
    Etiology  Common causes: Idiopathic  Trauma  high myopia  Other causes:  cystoid macular edema  proliferative diabetic retinopathy  severe hypertensive retinopathy  Choroidal neovasculatrisation  Solar retinopathy
  • 10.
    Classification  Primary macularhole: is commonly an idiopathic macular hole  Caused by vitreous traction on the foveal from an abnormal vitreous seperation  Secondary Macular hole: caused by other pathologies not associated with vitereomacular traction  blunt trauma, high myopia, macular telangiectasia type2, diff causes of macular oedema
  • 11.
    History  Macular holefirst recognized approximately 100 years ago  First described by Knapp in late 1800s  Later described by Noyes  First histopathologic descriptions of full-thickness macular holes were provided by Fuchs (1901)* and Coats (1907)**  Gass first described a series of stages of formation of idiopathic macular hole in 1988 *Fuchs E. Zur Veranderung der Macula Lutea Nach Contusion. Ztschr Augenheilk 1901;6:181 **Coats G. The pathology of macular holes. Roy Lond Hosp Rep 1907; 17-69
  • 12.
    Pathogenesis  Traumatic Theory* associated with direct or indirect ocular trauma  Trauma causes immediate macular hole formation from mechanical energy created by vitreous fluid waves and contrecoup macular necrosis or laceration  More common in young boys *Kopp CJ.Macular holes:a clinical contribution.Am ophthalmology 1908; 11:518-528
  • 13.
     Cystoid degenerationtheory*:  cystic degeneration of the central macula  due to :hypertension, retinal vessel occlusion, trauma  Cyst coalescence FTMH *Coats G. The pathology of macular holes. Roy London Hospital Report 1907; 17:69-96
  • 14.
     Vascular theory: Age related changes of retinal vasculature cystoid degeneration macular hole formation
  • 15.
     Vitreous Theory: Antero posterior fibrous traction band Macular traction Macular cystoid degeneration Macular hole
  • 16.
    Current theory Posteriorhyaloid applies traction to the foveola/umbo and causes it to stretch umbo dehisces because it is the thinnest point in the fovea middle and inner retina absorbs vitreous fluid at the exposed edges of the hole and begins to swell
  • 17.
    hole enlarges becauseof a lateral extension of fluid into the outer plexiform layer inner retina is breached due to the hydration of the fovea and perifoveal macula, the macular hole progresses
  • 18.
     Concept oftangential traction*  Spontaneous tangential traction of external part of the perifoveolar cortical vitreous detaches foveolar retina  Creates an intraretinal yellow spot approximately 100- 200μm in diameter  Yellow color may result from intraretinal xanthophyll pigment * Avila MP, Jalkh AE, Murakami K, et al. Biomicroscopic study of the vitreous in macular breaks. Ophthalmol 1983; 90:1277-83
  • 19.
    Role of ILMin pathogenesis of Macular Hole scaffold for proliferation of cellular components Like myofibroblasts, fibrocytes,RPE cells, fibrous astrocyts Causing tangential traction around fovea FTMH formation May also contribute to enlargement of MH
  • 20.
    Revised Gass classification: Gass first described a series of stages of formation of idiopathic macular hole * *GASS JIM. Reappraisal of biomicroscopically 0f stages of Development of a macular Hole. Am J Ophthalmolgy.1995; 119 :752-59
  • 21.
    Stage 1 a Spontaneous tangential traction of prefoveolar cortical vitreous detaches foveolar retina creating an intraretinal enhanced lipofuscin- colored yellow spot 100- 200μm in diameter Decreased/ absent foveal depression Foveolar detachment Retinal Pigment Epithelium Neurosensory RetinaPosterior Hyaloid Normal Fovea
  • 22.
    Stage 1 b Further traction causes foveal detachment  yellow spot ˆ200-300μm in diameter Foveal detachment
  • 23.
    Stage 2  Firstbiomicroscopically identifiable full thickness retinal defect  Less than 400μ Early hole, central Early hole, eccentric
  • 24.
    Stage 3  Vitreofovealseperation  Enlarges to greater than 400μ  Complete PVD is absent Stage 3 Hole
  • 25.
    Stage 4  Completeposterior vitreous detachment (Weiss’ ring) occurs in 20% - 40% of eyes Stage 4 Hole
  • 26.
    vitreous adhesion to centralmacula with no demonstrable retinal morphology changes vitreous adhesion to central macula , demonstrable changes like tissue cavitation, cystoid changes, loss of foveal contour, elevation of fovea Jay S et al. The International Vitreomacular Traction Study Group. Classification of vitreomacular adhesion, traction & macular hole. The American Academy of Ophthalmolgy. 2013.2611-19. OCT based anatomic classification of FTMH
  • 27.
    Small Hole ≥250μ,round or have a f flap adherent to vitreous, operculum ₊/- Medium FTMH hole 250 - 400μ, • round/ flap adherent to vitreous Large FTMH hole >400μ, • vitreous more likely to be fully seperated • from macula Jay S et al. The International Vitreomacular Traction Study Group. Classification of vitreomacular adhesion, traction & macular hole. The American Academy of Ophthalmolgy. 2013.2611-19. OCT based anatomic classification of FTMH
  • 29.
    Clinical features  Visualacuity the first indicator but sometimes misleading  Mild loss of central vision (Stage 1a & 1b)  Metamorphopsia
  • 30.
     FTMH isdiagnosed on slitlamp biomicroscopy  By off centering the beam we can study the contour of hole and vitreous interface differentiates FTMH from other lesions Positive & Negative Watzke - Allen Sign Watzke RC, Allen L. Subjective slit- beam sign for macular disease. Am J Ophthalmol 1969; 449 - 453
  • 31.
     In eyeswith ERM a fibrotic appearance with distortion of perifoveal vessels seen
  • 32.
     Amsler Grid: Small absolute scotomas can be detected in 30 -40 % of patients*  Charting used but not specific for macular hole  Can be used in post operative period to evaluate scotoma and metamorphopsia *Smith RG et al. Visual Performance in idiopathic macular holes. Eye 1990; 4: 190 - 194
  • 33.
  • 34.
     Optical coherencetomography (OCT):  diagnosis of macular hole but also in staging  helpful in prognosticating depending upon size of the macular hole
  • 35.
     Flourescein Angiography: Usually not indicated in diagnosis of macular hole  But generally demonstrates early hyperfluoresence (window defect)
  • 36.
     Laser AimingBeam Test:  Place a 50μm laser photocoagulator aiming beam within a lesion  Patient with FTMH cannot detect the aiming beam within lesion but is able to detect it in its surrounding  Patients with ERM or Pseudomacular hole shall be able to detect
  • 37.
     B- ScanUltrasonography:  Predictive of vitreomacular relationship and therefore may be helpful in staging
  • 38.
    Differential Diagnosis  Epiretinalmembrane with pseudomacular hole  Lamellar macular hole  Chronic cystoid macular edema
  • 39.
    ERM with Pseudomacularhole  have a median visual acuity of 20/30  retinal vascular tortuosity  not associated with a rim of subretinal fluid
  • 40.
    Lamellar macular hole Sharply circumscribed  Partial-thickness defects of the macula  Represents either as an aborted full-thickness lesions or a complication of chronic cystoid macular edema*  Characterized by a flat, reddish hue-type lesion with intact outer retinal tissue  Careful evaluation will reveal retinal tissue in the base of the lesion  No evidence of subretinal fluid  Do not progress to full-thickness lesions * Patel B, Duvall J, Tullo AB. Lamellar macular hole associated with idiopathic juxtafoveolar telangiectasia. Br J Ophthalmol 1988;72:550
  • 41.
  • 42.
    Chronic cystoid macularedema  Seen sometimes post cataract surgery  In diabetic macular edema
  • 43.
    Pre operative parameters Holeform factor > 0.9 and Macular Hole index > 0.5 also have a better prognosis a = base diameter, b = minimum diameter c = left arm length, d = right arm length
  • 44.
    Correlation of holeform factor and best corrected postoperative visual acuity S. Ullrich et al. Macular hole size as a prognostic factor in macular hole surgery. Br J Ophthalmol. 2002 Apr; 86(4): 390–393
  • 45.
    Management  Symptoms ofimpending holes : visual distortion, decreased visual acuity, and changes observed with home Amsler grid testing  Macular holes can resolve spontaneously
  • 46.
     This mostcommonly occurs in stage 1 but has been reported for stage 2 holes as well  The resolution occurs when the posterior hyaloid separates  Hence, it is better to observe them for a few months  If vision deteriorates or the hole progresses, vitreous surgery is indicated Management
  • 47.
    Surgery  Pars PlanaVitrectomy with internal limiting membrane peeling with gas tamponade is performed for stage 2-4 FTMH
  • 48.
    Pars Plana surgicalprocedures  Using three- port system  After removing central vitreous the posterior cortical vitreous is identified and seperated from retinal surface
  • 49.
    Chromovitrectomy  Use ofvital dyes to stain pre retinal tissues during vitreoretinal surgery  Allows visualization of the thin, transparent tissues in vitreoretinal interface : ILM, epiretinal ERM, or the vitreous posterior surface  Indocyanine Green Dye(ICG): 0.25mg/ml
  • 50.
     Trypan Blue(0.15%):stains ERM, but not ILM  Triamcinalone Acetonide(40mg/ml): stains residual vitreous  Brilliant Blue(0.025% & 0.05%): excellent stain for ilm, relatively non toxic
  • 51.
     In idiopathicFTMH the rationale would be to remove or relieve foveal traction from within the retinal surface1  Helps by ensuring complete removal of any epiretinal tissue above the ILM that could cause foveal traction2 as well as by increased cytokine release  enhancing glial proliferation ILM Peeling 1- Fekrat S, Wendel RE, de la Cruz Z, Green WR: clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole. Retina 1995; 1:53-57 2- Yooh HS, Brooks HL Jr, Capone A Jr, et al. Ultra structural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 1996;1:67-75
  • 52.
    Types of closure On the basis of post operative OCT findings closed macular holes are:  Type 1 & type 2 closure S W Kang et al. Types of macular hole closure and their clinical implications. Br J Ophthalmol 2003; 87: 1015 - 1019
  • 53.
    Type 1 Closure Indicates that macular hole is closed without foveal defect of the neurosensory retina
  • 54.
  • 55.
    Type 2 closure Indicates a foveal defect of neurosensory retina persists postoperatively  Although thewhole rim of macular hole is attached to the underlying RPE with flattening of the cuff
  • 56.
    Post operative parameters OCT parameters: Type 1 closure of MH without neurosensory defect) has a better visual outcome compared to Type 2 closure (with neurosensory defect)  Continuous IS/OS junction and external limiting membrane as well as increased photoreceptor outer segment thickness predicts a better functional outcome 1Kang ST, Ahn K, Ham DI. Types of macular hole closure and their clinical implications. Br J Ophthalmol. 2003; 87:1015-19 2San M, Shimoda Y, Hashimoto H.Restored photoreceptor outer segment and visual recovery after macular hole closure . Am J Ophthalmol 2009; 147:313-18
  • 57.
    Recent Advances Pharmacologic vitreolysis new nonsurgical option that can aid closure of macular holes associated with VMT  degrades the macromolecular vitreous attachment complex  relieves the tractional forces that cause the foveal lesion
  • 58.
     In MIVITRUST study patients with FTMHs less than 400 microns in width, the closure of holes occurred in 40.6% of ocriplasmin treated eyes and 10.6% of placebo treated eyes*  In patients with small hole the success rate was even higher  This occurred without face down position, surgery or gas bubble  Makes it an appealing option for appropriate patients * Stalmans P, Benz MS, Gandorfer A, Kampik A.et al. MIVITRUSTal study group. Enzymatic vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular holes.N Engl J Med 2012; 367: 606-15 Pharmacologic vitreolysis

Editor's Notes

  • #13 Note the irregularly shaped hole and the retinal pigmented epithelial (RPE) changes signifying prior trauma to the eye
  • #19 Atrophic fovea that has lost its normal architecture and appearance
  • #27 Peripapillary vitreous condensation ring
  • #30 Distinguishing feature: drusen like yellowish deposit in the base of the hole
  • #32 With the ring use of a thin slit beam during biomicroscopy, an absolute scotoma may appear to the patient as a break in the beam when it is centered over larger holes
  • #50 Ryan pg 2535
  • #51 ICG: excellent stain for ILM but causes RPE defects, visual field defects, Possible optic nerve atrophy TB : Relatively non toxic TA: makes ILM bulky facilitating easy removal.
  • #55 Color fundus photograph and vertical spectral-domain optical coherence tomography scan of case 1 at presentation showing stage IV macular hole (MH). (c, d) One month following primary surgery, the MH was open with a cuff of subretinal fl uid. (e, f) Following repeat fluid-gas exchange, type 1 closure occurred at 1-month follow-up
  • #57  pre-operative (a, c) and post-operative (b, d) result at most recent exam for cases of type 2 (c, d) closure. Type 1 closure demonstrates relative restoration of the outer retina compared with persistence of a central neurosensory retinal defect observed with type 2 closure
  • #58 preoperative (a), postoperative at 6 weeks (b), and 6 months (c). Foveal disruption of the photoreceptor layer is seen at 6 weeks after the surgery, whereas the ELM is continuous above the defect in IS–OS (BCVA 20 out of 60). At 6 months, the IS–OS layer has been completely restored (BCVA 20 out of 30). SD-OCT, spectral domain optical coherence tomography; ELM, external limiting membrane; IS–OS, inner segment–outer segment junction layer; ELMc/IS–OSd, ELM continuous and IS–OS discontinuous; BCVA, best-corrected visual acuity.
  • #62 Results of the MIVI IIT trial, macular hole. A. OCT demonstrating evidence of a stage 2 macular hole. B. OCT image three days after intravitreal injection